ACT-901

N/A

Report date: 2025/03/13 11:13:55
NME

Base Information

Drug NameACT-901
Drug Alias NameAFP-paclitaxelAlpha-fetoprotein-paclitaxel conjugateThird generation paclitaxel therapyACT-901
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTubulin inhibitorsApoptosis regulator Bcl-2 inhibitorsMitosis inhibitors +[4] 
TargetsApoptosis regulator Bcl-2Tubulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlpha Cancer Technologies
China Registration ClassN/A

Develop Information

Active CompaniesAlpha Cancer Technologies
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A